Financing - July 24, 2018
Modus Therapeutics completes 140 MSEK financing
The company announces that it has raised SEK 140 million in a financing led by new investor HealthCap, a European venture capital firm. HealthCap will invest SEK 60 million in a series A preferred financing. At the same time, existing shareholders will convert outstanding convertible notes into shares. The new equity investment together with the conversion, amounts […]
Financing - June 13, 2018
Immunitrack lands new investment for their AI platform
The money will be used to develop a computer program that can predict how the immune system will react to different substances, reports the company. Today, Immunitrack is offering contracted research to the pharmaceutical industry predicting how the immune system react to different pharmaceuticals, by producing reagents that can be used to examine the immune […]
Financing - June 13, 2018
Immunovia completes a directed share issue
The company has successfully completed a directed share issue, which will provide it with a gross proceed of approximately SEK 324 million. The board of directors of Immunovia has resolved on a directed share issue of 2,162,794 new shares at a subscription price of SEK 150 per share. The subscription price in the Share Issue […]
Biotech Business - May 24, 2018
Keensight Capital invests in Biovian
Keensight Capital hopes to mobilize significant resources to help the management team to implement a strategic development plan to become a European leader. “We are very pleased to team up with Keensight Capital and welcome such a respected investor as a partner. Thanks to their support, we intend to develop our offer and know-how on […]
Collaboration - March 30, 2018
Call for proposals for funding of Nordic personalized medicine project
The Swedish Governmental Agency for Innovation Systems (Vinnova), the Icelandic Centre for Research (RANNÍS), Innovation Fund Denmark, Innovaatiorahoituskeskus Business Finland and the Research Council of Norway, in collaboration with NordForsk, are launching a call for proposals for funding of trans-Nordic projects aimed at implementation of personalized medicine in health care. Partnerships and innovation networks are […]
Financing - March 5, 2018
Gesynta Pharma secures 22 MSEK in funding
The company announces the completion of series A round of financing, intended to provide funds for completion of pre-clinical development of its lead candidate, GS-248. A consortium of seasoned life sciences investors will provide financial and strategic support to the development program and bring the company to its next pivotal milestone, to initiate clinical trials […]
